Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study.

PubWeight™: 2.17‹?› | Rank: Top 2%

🔗 View Article (PMID 16920077)

Published in Biol Psychiatry on August 22, 2006

Authors

G Paul Amminger1, Gregor E Berger, Miriam R Schäfer, Claudia Klier, Max H Friedrich, Martha Feucht

Author Affiliations

1: Department of Child and Adolescent Neuropsychiatry, Medical University of Vienna, Vienna, Austria. paul.amminger@meduniwien.ac.at

Associated clinical trials:

Understanding Sleep Problems in Children With Autism Spectrum Disorder (REST) | NCT00691080

Articles citing this

Evolving the future: toward a science of intentional change. Behav Brain Sci (2014) 17.47

The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis. Schizophr Res (2010) 2.78

Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis (2007) 1.51

Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children. Eur J Pediatr (2009) 1.49

Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis (2012) 1.35

Oxidative Stress and Erythrocyte Membrane Alterations in Children with Autism: Correlation with Clinical Features. PLoS One (2013) 1.10

Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother (2010) 1.10

A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord (2011) 1.06

A review of complementary and alternative treatments for autism spectrum disorders. Autism Res Treat (2012) 1.04

Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am (2008) 1.01

Omega-3 fatty acids for autistic spectrum disorder: a systematic review. J Autism Dev Disord (2009) 0.99

The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J Neuroinflammation (2012) 0.98

A Randomized Controlled Trial of Individual Family Psychoeducational Psychotherapy and Omega-3 Fatty Acids in Youth with Subsyndromal Bipolar Disorder. J Child Adolesc Psychopharmacol (2015) 0.96

Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan. Nutrients (2010) 0.96

Micronutrients versus standard medication management in autism: a naturalistic case-control study. J Child Adolesc Psychopharmacol (2010) 0.93

Complementary and alternative medicine in autism: an evidence-based approach to negotiating safe and efficacious interventions with families. Neurotherapeutics (2010) 0.90

Complementary alternative medicine for children with autism: a physician survey. J Autism Dev Disord (2009) 0.89

Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Am Acad Child Adolesc Psychiatry (2014) 0.89

A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism. Mol Autism (2015) 0.89

A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel. Front Public Health (2013) 0.88

Improving the prediction of response to therapy in autism. Neurotherapeutics (2010) 0.87

Review of the pharmacotherapy of irritability of autism. J Can Acad Child Adolesc Psychiatry (2012) 0.86

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications. Curr Opin Pediatr (2011) 0.85

Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease. Prostaglandins Leukot Essent Fatty Acids (2011) 0.85

Complementary and Alternative Therapies for Autism Spectrum Disorder. Evid Based Complement Alternat Med (2015) 0.84

Regarding "omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study". Biol Psychiatry (2007) 0.84

Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore. Eur J Clin Nutr (2015) 0.83

Reduced levels of plasma polyunsaturated fatty acids and serum carnitine in autistic children: relation to gastrointestinal manifestations. Behav Brain Funct (2015) 0.82

Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells--possible relevance to autism spectrum disorders. PLoS One (2014) 0.81

Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data. J Clin Med (2016) 0.80

N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology. Int J Neuropsychopharmacol (2016) 0.80

Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids. J Psychosom Res (2013) 0.79

(N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders. Adv Nutr (2012) 0.79

Neuroinflammation in Autism: Plausible Role of Maternal Inflammation, Dietary Omega 3, and Microbiota. Neural Plast (2016) 0.77

Autism spectrum disorders. Glob Adv Health Med (2012) 0.76

The role of nutraceuticals in the management of autism. Saudi Pharm J (2012) 0.76

Potential serum biomarkers from a metabolomics study of autism. J Psychiatry Neurosci (2016) 0.75

Behavioral vaccines and evidence-based kernels: nonpharmaceutical approaches for the prevention of mental, emotional, and behavioral disorders. Psychiatr Clin North Am (2011) 0.75

Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial. Trials (2016) 0.75

Soy Infant Formula may be Associated with Autistic Behaviors. Autism Open Access (2013) 0.75

Relationship between Long Chain n-3 Polyunsaturated Fatty Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of Case-Control and Randomised Controlled Trials. Nutrients (2017) 0.75

Treatment of Autism Spectrum Disorder in Children and Adolescents. Psychopharmacol Bull (2016) 0.75

A preliminary investigation into the potential role of waist hip ratio (WHR) preference within the assortative mating hypothesis of autistic spectrum disorders. J Autism Dev Disord (2008) 0.75

Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms. J Autism Dev Disord (2017) 0.75

Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat (2017) 0.75

Articles by these authors

15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet (2009) 6.21

Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain (2009) 3.96

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2010) 3.82

Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome. J Clin Psychiatry (2012) 2.31

Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia (2014) 2.15

Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol (2009) 1.73

Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet (2013) 1.59

Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet (2012) 1.48

Pilot study evaluating the effect of massage therapy on stress, anxiety and aggression in a young adult psychiatric inpatient unit. Aust N Z J Psychiatry (2008) 1.46

Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry (2005) 1.24

DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol (2014) 1.21

Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol Psychiatry (2007) 1.17

A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity. Hum Mol Genet (2006) 1.16

Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI. Acta Neuropathol (2011) 1.11

Suicidality, psychopathology, and gender in incarcerated adolescents in Austria. J Clin Psychiatry (2007) 1.06

Emotion recognition in individuals at clinical high-risk for schizophrenia. Schizophr Bull (2011) 1.04

Mental health issues in unaccompanied refugee minors. Child Adolesc Psychiatry Ment Health (2009) 1.04

Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation. Neurobiol Dis (2008) 1.03

Consensus on diagnosis and management of JME: From founder's observations to current trends. Epilepsy Behav (2013) 1.01

Hippocampus abnormalities in at risk mental states for psychosis? A cross-sectional high resolution region of interest magnetic resonance imaging study. J Psychiatr Res (2009) 1.01

The International Study on General Practitioners and Early Psychosis (IGPS). Schizophr Res (2008) 0.98

Disconnective surgery in posterior quadrantic epilepsy: experience in a consecutive series of 10 patients. Neurosurg Focus (2013) 0.97

Predictors for negative attitudes toward subjects with epilepsy: a representative survey in the general public in Austria. Epilepsia (2005) 0.95

Genome-wide linkage meta-analysis identifies susceptibility loci at 2q34 and 13q31.3 for genetic generalized epilepsies. Epilepsia (2012) 0.94

Filicide in Austria and Finland--a register-based study on all filicide cases in Austria and Finland 1995-2005. BMC Psychiatry (2009) 0.92

Suicidal ideation among Viennese high school students. Wien Klin Wochenschr (2007) 0.92

[Autocastration of a young schizophrenic man]. Psychiatr Prax (2002) 0.91

Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning. Schizophr Res (2012) 0.90

Speech and school performance in children with benign partial epilepsy with centro-temporal spikes (BCECTS). Seizure (2009) 0.90

Suicide in Austrian children and young adolescents aged 14 and younger. Eur Child Adolesc Psychiatry (2006) 0.89

Long-term outcome and tolerability of the ketogenic diet in drug-resistant childhood epilepsy--the Austrian experience. Seizure (2010) 0.89

A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis. Schizophr Res (2008) 0.88

Olfactory sensitivity through the course of psychosis: Relationships to olfactory identification, symptomatology and the schizophrenia odour. Psychiatry Res (2006) 0.88

Parietal lobes in schizophrenia: do they matter? Schizophr Res Treatment (2011) 0.87

Linkage and association analysis of CACNG3 in childhood absence epilepsy. Eur J Hum Genet (2007) 0.86

Experience with generic drugs in epilepsy patients: an electronic survey of members of the German, Austrian and Swiss branches of the ILAE. Epilepsia (2007) 0.86

Evaluation of CACNA1H in European patients with childhood absence epilepsy. Epilepsy Res (2006) 0.86

[Early detection of psychotic disorders]. Neuropsychiatr (2007) 0.86

Linkage and mutational analysis of CLCN2 in childhood absence epilepsy. Epilepsy Res (2007) 0.86

Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls. Early Interv Psychiatry (2012) 0.86

Beneficial effect of epilepsy surgery in a case of childhood non-paraneoplastic limbic encephalitis. Epilepsy Res (2010) 0.86

Sex-specific predictors of criminal recidivism in a representative sample of incarcerated youth. Compr Psychiatry (2008) 0.85

State and trait emotions in delinquent adolescents. Child Psychiatry Hum Dev (2007) 0.85

Adaptive behaviour in Down syndrome: a cross-sectional study from childhood to adulthood. Wien Klin Wochenschr (2010) 0.85

Adhesio interthalamica in individuals at high-risk for developing psychosis and patients with psychotic disorders. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.84

Genome wide high density SNP-based linkage analysis of childhood absence epilepsy identifies a susceptibility locus on chromosome 3p23-p14. Epilepsy Res (2009) 0.84

Dynamic up-regulation of prodynorphin transcription in temporal lobe epilepsy. Hippocampus (2009) 0.84

Vertical perithalamic hemispherotomy: a single-center experience in 40 pediatric patients with epilepsy. Epilepsia (2013) 0.84

Long-term follow-up of patients with congenital hyperinsulinism in Austria. J Pediatr Endocrinol Metab (2008) 0.84

Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry (2006) 0.84

Glutamate decarboxylase 67 is expressed in hippocampal mossy fibers of temporal lobe epilepsy patients. Hippocampus (2011) 0.84

Frameless stereotactic drilling for placement of depth electrodes in refractory epilepsy: operative technique and initial experience. Neurosurgery (2014) 0.84

Frontal delta power associated with negative symptoms in ultra-high risk individuals who transitioned to psychosis. Schizophr Res (2012) 0.84

Suicide among Viennese minors, 1946-2002. Wien Klin Wochenschr (2006) 0.83

Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study. Psychiatry Res (2010) 0.83

Youth suicide risk factors and attitudes in New York and Vienna: a cross-cultural comparison. Suicide Life Threat Behav (2006) 0.83

Analysis of ELP4, SRPX2, and interacting genes in typical and atypical rolandic epilepsy. Epilepsia (2014) 0.82

St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants. J Clin Psychiatry (2006) 0.82

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective? Schizophr Res (2013) 0.81

Tuberous Sclerosis Complex: new criteria for diagnostic work-up and management. Wien Klin Wochenschr (2015) 0.81

Type 1 diabetes and epilepsy: efficacy and safety of the ketogenic diet. Epilepsia (2010) 0.81

Pituitary volume increase during emerging psychosis. Schizophr Res (2010) 0.80

Semiology of temporal lobe epilepsy in children and adolescents. Value in lateralizing the seizure onset zone [corrected]. Epilepsy Res (2002) 0.80

Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12. World J Biol Psychiatry (2010) 0.80

The effect of atypical antipsychotics on pituitary gland volume in patients with first-episode psychosis: a longitudinal MRI study. Schizophr Res (2010) 0.79

Effects of parental soothing behavior on stress levels of 2-8 year old children during voiding cystourethrograms by phase of procedure. J Clin Psychol Med Settings (2011) 0.79

Comparing stress levels in children aged 2-8 years and in their accompanying parents during first-time versus repeated voiding cystourethrograms. Wien Klin Wochenschr (2008) 0.79

Combined electroencephalography and magnetoencephalography of interictal spikes in benign rolandic epilepsy of childhood. Clin Neurophysiol (2008) 0.79

Attitudes toward suicide and help-seeking in Hungarian adolescents. J Am Acad Child Adolesc Psychiatry (2005) 0.78

Nonlinear Directed Interactions Between HRV and EEG Activity in Children With TLE. IEEE Trans Biomed Eng (2016) 0.77

Convergent Cross Mapping: Basic concept, influence of estimation parameters and practical application. Conf Proc IEEE Eng Med Biol Soc (2015) 0.77

Insight in relation to psychosocial adjustment in schizophrenia. J Nerv Ment Dis (2004) 0.77

Relational memory in first episode psychosis: implications for progressive hippocampal dysfunction after illness onset. Aust N Z J Psychiatry (2011) 0.77

The expanding mutational spectrum of MERRF substitution G8361A in the mitochondrial tRNALys gene. Ann Neurol (2003) 0.77

Responses to conflict, family loss and flight: posttraumatic stress disorder among unaccompanied refugee minors from Africa. Neuropsychiatr (2014) 0.77

[On the work of Austrian authorised experts on procedures in custodial and visiting rights--a survey of current practice from the parents and children view]. Neuropsychiatr (2008) 0.77

Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial. Can J Psychiatry (2013) 0.76

Psychosocial background in incarcerated adolescents from Austria, Turkey and former Yugoslavia. Psychiatry Res (2011) 0.76

Pathways to dissociation: intrafamilial versus extrafamilial trauma in juvenile delinquents. J Nerv Ment Dis (2003) 0.76

Juvenile myoclonic epilepsy: a benign disorder? Personality traits and psychiatric symptoms. Epilepsy Behav (2007) 0.76

Changes in body mass index during long-term topiramate therapy in paediatric epilepsy patients--a retrospective analysis. Seizure (2004) 0.76

Neuropsychology and behavior in juvenile myoclonic epilepsy. Epilepsy Behav (2013) 0.76

Insight, symptoms and executive functions in schizophrenia. Cogn Neuropsychiatry (2006) 0.76

[Suicide in children and adolescents]. Wien Klin Wochenschr (2006) 0.75

Affect recognition and functioning in putatively prodromal individuals. Schizophr Res (2013) 0.75

Metabolic changes in first-episode early-onset schizophrenia with second-generation antipsychotics. Early Interv Psychiatry (2013) 0.75

Review: limited evidence from two small trials suggests no improvement in ASD symptoms with short term ω-3 supplementation. Evid Based Ment Health (2012) 0.75

Time-variant, frequency-selective, linear and nonlinear analysis of heart rate variability in children with temporal lobe epilepsy. IEEE Trans Biomed Eng (2014) 0.75

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial. Trials (2014) 0.75

Midbrain-hindbrain malformations in patients with malformations of cortical development and epilepsy: a series of 220 patients. Epilepsy Res (2013) 0.75

Synchronization analysis between heart rate variability and EEG activity before, during, and after epileptic seizure. Biomed Tech (Berl) (2014) 0.75

Advantages of signal-adaptive approaches for the nonlinear, time-variant analysis of heart rate variability of children with temporal lobe epilepsy. Conf Proc IEEE Eng Med Biol Soc (2014) 0.75

Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: a double-blind, placebo-controlled study. Psychoneuroendocrinology (2008) 0.75

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis. Psychother Psychosom (2017) 0.75

Matching Pursuit-Based Time-Variant Bispectral Analysis and its Application to Biomedical Signals. IEEE Trans Biomed Eng (2015) 0.75